USP25 and cancer: Notably, aberrant expression of ubiquitin specific peptidase 25 (USP25) has been reported to be associated with poor prognosis in various cancer types and evidence suggests that it promotes tumor growth, metastasis, and the chemotherapeutic response [21–23].